| # | Drug | Count |
|---|---|---|
| 0 | RIVAROXABAN | 230 |
| 1 | BEVACIZUMAB | 196 |
| 2 | PREDNISONE | 186 |
| 3 | DEXAMETHASONE 1.5 MG | 168 |
| 4 | DEXAMETHASONE | 167 |
| 5 | QUETIAPINE | 122 |
| 6 | LENALIDOMIDE | 121 |
| 7 | ETONOGESTREL AND ETHINYL ESTRADIOL | 119 |
| 8 | METHOTREXATE SODIUM | 119 |
| 9 | CYCLOPHOSPHAMIDE | 113 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BARRIER CREAM | 1 | 0.0588 |
| 1 | LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS | 2 | 0.0238 |
| 2 | LAZERTINIB | 9 | 0.0104 |
| 3 | PRAMOXINE HYDROCHLORIDE HYDROCORTISONE ACETATE | 8 | 0.0099 |
| 4 | AMIVANTAMAB-VMJW | 35 | 0.0098 |
| 5 | CARBON DIOXIDE | 1 | 0.0087 |
| 6 | PSYLLIUM HUSK | 11 | 0.0081 |
| 7 | ANGIOTENSIN II | 2 | 0.0067 |
| 8 | ZINC SULFATE INJECTION, | 17 | 0.0059 |
| 9 | BELINOSTAT | 2 | 0.0056 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 475 |
| 1 | Atypical Antipsychotic [EPC] | 310 |
| 2 | Factor Xa Inhibitor [EPC] | 287 |
| 3 | Platinum-based Drug [EPC] | 235 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 211 |
| 5 | Estrogen [EPC] | 209 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 204 |
| 7 | Progestin [EPC] | 162 |
| 8 | Alkylating Drug [EPC] | 157 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 157 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vasoconstrictor [EPC] | 2 | 0.0067 |
| 1 | Interferon gamma Blocker [EPC] | 1 | 0.0042 |
| 2 | Typical Antipsychotic [EPC] | 89 | 0.0036 |
| 3 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 4 | Anti-coagulant [EPC] | 8 | 0.0021 |
| 5 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 13 | 0.0021 |
| 6 | Antifibrinolytic Agent [EPC] | 18 | 0.0018 |
| 7 | Histone Deacetylase Inhibitor [EPC] | 7 | 0.0018 |
| 8 | Diagnostic Dye [EPC] | 1 | 0.0015 |
| 9 | Polyene Antifungal [EPC] | 53 | 0.0013 |